- Study involved 1,030 pediatric patients.
- Ondansetron post-discharge reduced moderate-to-severe gastroenteritis risk.
- 5.1% vs. 12.5% severe illness in ondansetron vs. placebo.
- Significant vomiting frequency improvement in ondansetron group.
- Study conducted in pediatric EDs across Canada.
Ondansetron Cuts 7-Day Gastroenteritis Severity in Children, Study Finds
Conexiant
July 30, 2025